Meanwhile, consistent with previous reports, we also found that the expression levels of CEA and HER-2 were significantly correlated with the therapeutic response to nCRT in patients with advanced CRC (P<0.05;Table 3) [23,24] . This evidence concerns the gene CEACAM5 and colorectal carcinoma.